Events

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings worldwide. See below for a list of past and upcoming events.

EUFEMED, 3rd Annual Conference, 28-30 April 2021

Event Date:
28-30 April 2021
Location:
Virtual Meeting

Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.

View Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

Event Date:
4 – 5 December 2020
Location:
Virtual Meeting

The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.

View Event

Association for Human Pharmacology in the Pharmaceutical Industry Christmas Lecture

Event Date:
15 December 2020, 14:00 – 16:30 (GMT)
Location:
Virtual Meeting

This year’s lectures will include a presentation by Richmond Pharmacology’s CEO and Founder, Jorg Taubel M.D.

View Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

Event Date:
21 - 23 September 2020
Location:
Virtual Meeting

Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.

View Event

On Helix, Transforming new medicine discovery

Event Date:
13-14 July 2020
Location:
Digital

Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.

View Event

Cardiac Safety London

Event Date:
Wednesday 20th May 2020 - 10am – 3.30pm BST
Location:
Online Event

To help to enrich and speeding up your drug development programs, join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss the latest state of the art methods...

View Event

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more